Jitendra Banweer

@sageuniversity.edu.in

SANJEEV AGRAWAL GLOBAL EDUCATIONAL UNIVERSITY

Jitendra Banweer

RESEARCH, TEACHING, or OTHER INTERESTS

General Pharmacology, Toxicology and Pharmaceutics, Drug Discovery, Pharmaceutical Science, Pharmacology
10

Scopus Publications

887

Scholar Citations

14

Scholar h-index

15

Scholar i10-index

Scopus Publications

  • Selection of excipients for Ethosome Formulations of Imiquimod through Drug–excipient Compatibility testing for Skin Cancer: A Pre-Formulation Study
    Bharti Choudhary, Jitendra Banweer
    Research Journal of Pharmacy and Technology, 2026
    Skin cancer is a prevalent global issue, with traditional therapies often lacking drug penetration and bioavailability. Ethosomes, lipid-based vesicles, offer a promising solution for transdermal drug delivery, encapsulating both hydrophilic and lipophilic drugs and providing superior skin penetration. Imiquimod, an immune response modifier, is commonly used to treat non-melanoma skin cancers, but its effectiveness is hindered by poor skin penetration and local irritation. Ethosomal formulations offer an innovative approach to improve the bioavailability and therapeutic effect of Imiquimod by facilitating deeper skin penetration and sustained release. The development of ethosomes requires the careful selection of excipients that are compatible with both the drug and the delivery system. In this study, Phosphatidylcholine, Ethanol, and Propylene Glycol were chosen as excipients for the formulation of Imiquimod-loaded ethosomes. Phosphatidylcholine serves as the key phospholipid for vesicle formation, while Ethanol and Propylene Glycol act as solvents and penetration enhancers. Imiquimod's compatibility with excipients was investigated utilizing methods such as DSC, FTIR, XRD, and UV to identify any possible interactions. The results confirmed that Imiquimod is compatible with Phosphatidylcholine, Ethanol, and Propylene Glycol, with no significant chemical interactions. This indicates the suitability of these excipients for the future development of Imiquimod-loaded ethosomal formulations for the treatment of skin cancer, ensuring both stability and enhanced therapeutic efficacy.
  • Therapeutic Potential Of Nyctanthes Arbor Tristis In The Treatment Of Rheumatoid Arthritis
    Gauri Bhivshet, Jitendra Banweer
    International Journal of Drug Delivery Technology, 2026
    Rheumatoid arthritis (RA) is a progressive autoimmune disorder characterized by chronic joint inflammation, cartilage degradation, and elevated pro-inflammatory cytokines. The current study investigates the therapeutic potential of Nyctanthes arbor-tristis (NAT) using compiled secondary data from phytochemical, in-vitro, in-vivo, and in-silico studies. Analysis of existing literature revealed that NAT contains iridoid glycosides, flavonoids, phenolic acids, and terpenoids that contribute to its anti-inflammatory, antioxidant, and immunomodulatory properties. Animal-model evidence demonstrates significant reductions in paw edema (42–65%), suppression of pro-inflammatory cytokines including TNF-α, IL-6, and IL-1β, and enhancement of antioxidant enzymes such as SOD, catalase, and glutathione. Structural joint protection, including reduced synovial hyperplasia and preserved cartilage, further supports its therapeutic relevance. A comparison with conventional RA drugs indicates that while synthetic medications offer stronger immediate cytokine suppression, they are associated with adverse effects and high cost. NAT, however, provides a safer, multi-target, low-cost alternative suitable for long-term management. Overall, this review consolidates evidence supporting NAT as a promising adjunct or complementary therapeutic option in RA management.
  • Impact of Vitex Nigunda Linn on the treatment of Rheumatoid Arthritis
    Gauri Bhivshet, Dr. Jitendra Banweer
    International Journal of Drug Delivery Technology, 2025
    Vitex negundo Linn (family Verbenaceae), commonly known as Nirgundi, is a medicinal plant extensively used in traditional Ayurvedic systems for treating inflammatory and rheumatic disorders. This review combines recent scientific data on its pharmacological, biochemical, and clinical potential in the management of Rheumatoid Arthritis (RA). This plant has a wide variety of therapeutic effects such as anti-inflammatory, anti-oxidant, analgesic, and immunomodulatory effects mainly inhibited by COX, LOX, TNF-α, IL-1β and NF-κB signaling pathways. The therapeutic benefits are attributed to bioactive compounds such as casticin, negundoside and luteolin contributing to the multi-targeted therapeutic paradigm. The pre-clinical applicability is attractive and is associated with a clinically meaningful beneficial impact on joint inflammation, oxidative stress, and cytokine balance and safety confirmed with positive toxicology. The limitations are in clinical validation and standardization. The way forward would be to focus on multi-centric clinical studies and mechanistic studies using medical-omics approaches to better understand the favorable outcomes of V. negundo, including innovative formulations to optimize bioavailability and reproducibility. Overall, V. negundo Linn is defined as a multifaceted complementary or adjunct treatment option for the management of RA, bridging traditional knowledge with contemporary pharmacology.
  • A Review on Liposomes as Novel Drug Delivery System
    Bharti Choudhary, Jitendra Banweer
    Research Journal of Pharmacy and Technology, 2025
    Liposomes, spherical vesicles made of phospholipids and cholesterol, are a potential drug delivery mechanism due to their large size, hydrophobic and lipophilic properties. They exhibit high biocompatibility and stability, allowing for the encapsulation of both hydrophilic and lipophilic drugs. Their amphiphatic structure allows for regulated drug release within their compartments. Liposomes are used in treating various ailments like tumors and cancer. This comprehensive review of the Liposomal Drug Delivery System explores various aspects related to liposomes.
  • Formulation and Characterization of Niosomal Gel for Topical Treatment of Psoriasis
    , Mansi Gupta, Sarika Shrivastava, , Jitendra Banweer, and
    International Journal of Drug Delivery Technology, 2025
    The aim of the research work was to formulate and characterize the Calcipotriol loaded niosomal gel for the topical treatment of psoriasis through application of different polymers. Psoriasis is a chronic skin condition in which the skin develops areas that become thick and covered with silvery scales. For psoriasis treatment, topical application is preferred in spite of other dosage form. Use of Fourier transform infrared Spectroscopy (FT-IR) showed that Calcipotriol was compatible with other excipients in terms of its physical and chemical nature. The gels formulated were analysed for their viscosity, extruding potential, drug content, test of skin irritation, pH of final formulation, along with its stability and invitro diffusion profile. The process includes the release of Calcipotriol from all prepared formulations by using dialysis membrane in the pH 6.8 phosphate buffer at 37°C temperature. This characterization study allowed to select the optimized batch from among the formulations prepared. From the data gathered it was ascertained that Calcipotriol has the potential in being used in gel formulation for the therapeutic management of psoriasis.
  • Current scenario of nutraceuticals and food fortification in India
    Health Biotechnology and Biopharma, 2020
  • Development and evaluation of aceclofenac transdermal patches with different permeation enhancers
    Der Pharmacia Lettre, 2015
  • Formulation, development and evaluation of cefaclor extended release matrix tablet
    International Journal of Pharmacy and Pharmaceutical Sciences, 2012
  • Development and optimization of transdermal system of lisinopril dehydrate: Employing permeation enhancers
    Iranian Journal of Pharmaceutical Sciences, 2010
  • Osmotically controlled drug delivery system with associated drugs
    Brahma Prakash Gupta, Navneet Thakur, Nishi P Jain, Jitendra Banweer, Surendra Jain
    Journal of Pharmacy and Pharmaceutical Sciences, 2010
    Conventional drug delivery systems have slight control over their drug release and almost no control over the effective concentration at the target site. This kind of dosing pattern may result in constantly changing, unpredictable plasma concentrations. Drugs can be delivered in a controlled pattern over a long period of time by the controlled or modified release drug delivery systems. They include dosage forms for oral and transdermal administration as well as injectable and implantable systems. For most of drugs, oral route remains as the most acceptable route of administration. Certain molecules may have low oral bioavailability because of solubility or permeability limitations. Development of an extended release dosage form also requires reasonable absorption throughout the gastro-intestinal tract (GIT). Among the available techniques to improve the bioavailability of these drugs fabrication of osmotic drug delivery system is the most appropriate one. Osmotic drug delivery systems release the drug with the zero order kinetics which does not depend on the initial concentration and the physiological factors of GIT. This review brings out new technologies, fabrication and recent clinical research in osmotic drug delivery.

RECENT SCHOLAR PUBLICATIONS

  • Phytosomes as a Promising Nano-Phytopharmaceutical Approach for the Anti-Arthritic Delivery of Phytoconstituents.
    P Jain, J Banweer
    Journal of Chemical Health Risks 15 (5), 3468 , 2025
    2025
  • Exploring the Antiarthritic Effects of a Polyherbal Formulation in Experimental Animal Models.
    P Jain, J Banweer
    Journal of Chemical Health Risks 15 (5), 1018 , 2025
    2025
  • Formulation and Characterization of Ketoconazole Transferosomal Gel for Effective Topical Fungal Treatment
    J Banweer, N Vishwas, RK Jain
    International Journal of Research and Scientific Innovation (IJRSI) 12 (9) , 2025
    2025
  • Formulation of a Moisturising Hand Cream Using Shea Butter, Sodium Alginate, and Sweet Almond Oil: A Review
    S Singh, K Upadhyay, S Shrivastava, J Banweer
    Asian Journal of Pharmaceutical Research and Development 13 (3), 105-107 , 2025
    2025
  • Impact of Opioid Toxicity on Workplace Productivity
    PK Mishra, S Khare, J Banweer
    International Journal of Scientific Research and Technology 2 (5), 401-407 , 2025
    2025
  • OVERVIEW OF IN VITRO METHODS FOR EVALUATING ANTICANCER ACTIVITY AND THE ANTICANCER POTENTIAL OF INDIAN MEDICINAL PLANTS
    S Joshi, S Shrivastava, J Banweer
    Cuestiones de Fisioterapia 54 (4), 6563-6570 , 2025
    2025
  • Formulation And Evaluation of Transdermal Patches of Anti-Cancer Drug Containing Natural Penetration Enhancer.
    V Rai, J Banweer, S Khare
    2025
  • Formulation Development And Evaluation Of Gastroretentive Microspheres Of Antidiabetic Drug Saxagliptin
    JBPTRAJ KUMAR
    AFRICAN JOURNAL OF BIOLOGICAL SCIENCES 6 (1), 2256-2263 , 2024
    2024
  • TIME-RELEASE FORMULATION OF ROSMARINIC ACID AS A POTENTIAL APPLICATION FOR SLEEP DISORDERS
    jitendra banweer abhijeet morde praveen tahilani
    INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH 13 (1), 1-5 , 2024
    2024
  • Hair growth stimulating effect and phytochemical evaluation hydoalcoholic extract of Carica papaya leaves
    I Dangi, M Sahu, L Verma, J Banweer
    World J. Pharm. Res 12, 169-776 , 2023
    2023
    Citations: 1
  • AN UPDATE ON NANOGEL & FLURBIPROFEN
    JBR SHARMA
    AEGAEUM JOURNAL 11 (12), 54-65 , 2023
    2023
  • Role of Irioid Glycoside for the treatment of Rhematoid Arthritis
    GU Bhivshet
    International Neurology Journal 27 (4), 1080-1086 , 2023
    2023
  • ADVANCES IN PSORIASIS TREATMENT : LATEST UPDATES ON CURRENT & FUTURE OPTIONS FOR MODERATE TO SEVERE PLAQUE PSORIASIS
    JBS SHRIVASTAVA
    ORGANIZATION DEVELOPMENT JOURNAL 11 (12), 132-142 , 2023
    2023
  • Phytochemical and Pharmacological Evaluation of Andrographis Paniculata and Vitex Negundo for Analgesic Activity
    SMK Sen D, Banweer J, Verma, L
    Journal of Pharmaceutical & Clinical Research. 16 (1), 41-44 , 2023
    2023
  • Phytochemical & Pharmacological Activity of Datura Metal & Calendula Officinalis
    BJ Sahu MK
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES 10 (9), 76-81 , 2023
    2023
  • Anti-oxidant and Anti-Pyretic activity of Hydro-alcoholic extract of Cassia Auriculata”,
    BJ Sahu M K
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES 10 (6), 577-581 , 2023
    2023
  • An Overview on Mucoadhesive Drug Delivery System
    JB Namdev S, Kapadia R
    International journal of Pharmaceutical and Biological Sciences 11 (2) , 2023
    2023
  • Rosmarinic Acid-A Potential Therapeutic Agent for Sleep Disorders.
    BJ Morde A, Acharya M, Tahilani P
    International Journal on Pharmacy & Sciences 3 (1), 1-6 , 2023
    2023
    Citations: 4
  • Formulation And Evaluation of Psidium Guava & Curcuma Longa Extract Based Chewing Gum For Treating Mouth Ulcer.
    BJ Mishra P, Tahilani P, Shrivastava S
    International Journal of Drug Discovery & Herbal Research. 13 (2), 34-39 , 2023
    2023
  • Formulation & Development of Levofloxacin & Diclofenac Formulation Loaded Microemulgel For The Treatment of Bacterial Infection Transdermal Route.
    SP Mishra P, Tahilani P, Shrivastava S, Banweer J
    JOURNAL OF EMERGING TECHNOLOGIES AND INNOVATIVE RESERACH 11 (1), 53-56 , 2023
    2023

MOST CITED SCHOLAR PUBLICATIONS

  • Phytosome: a novel drug delivery system for herbal medicine
    N Jain, BP Gupta, N Thakur, R Jain, J Banweer, DK Jain, S Jain
    Int J Pharm Sci Drug Res 2 (4), 224-228 , 2010
    2010
    Citations: 201
  • Osmotically controlled drug delivery system with associated drugs
    BP Gupta, N Thakur, NP Jain, J Banweer, S Jain
    Journal of Pharmacy & Pharmaceutical Sciences 13 (4), 571-588 , 2010
    2010
    Citations: 184
  • Nanotechnology: a safe and effective drug delivery system
    JBNJDK JAIN
    ASIAN JOURNAL OF PHARMACEUTICAL & CLINICAL RESEARCH 3 (3), 159-165 , 2010
    2010
    Citations: 130
  • A review on solubility enhancement using hydrotropic phenomena
    VS Kumar, C Raja, C Jayakumar
    Int. J. Pharm. Pharm. Sci 6 (6), 1-7 , 2014
    2014
    Citations: 105
  • A brief view on antihypertensive drugs delivery through transdermal patches
    V Rastogi, PU Pragya
    International Journal Of Pharmaceutical Sciences And Research 3 (7), 1955 , 2012
    2012
    Citations: 29
  • A review on Griffonia simplicifollia-an ideal herbal anti-depressant
    PS Kumar, T Praveen, NP Jain, B Jitendra
    International Journal of Pharmacy & Life Sciences 1 (3), 174-181 , 2010
    2010
    Citations: 27
  • Formulation, development and evaluation of cefaclor extended release matrix tablet
    A Patel, JP Rai, DK Jain, JI Banweer
    Int J Pharm Pharm Sci 4 (4), 355-7 , 2012
    2012
    Citations: 26
  • Effect of superdisintegrants on formulation of taste masked fast disintegrating Ciprofloxacin tablets
    N Jain, S Mandal, J Banweer, S Jain
    International current pharmaceutical journal 1 (4), 62-67 , 2012
    2012
    Citations: 26
  • Novel spectrophotometric quantitative estimation of Hydrochlorothiazide in bulk drug and their dosage forms by using hydrotropic agent
    N Jain, R Jain, N Thakur, BP Gupta, J Banweer, S Jain
    Int J Appl Pharm 2 (3), 11-14 , 2010
    2010
    Citations: 26
  • Novel spectrophotometric quantitative estimation of torsemide in tablets using mixed hydrotropic agent
    N Jain, R Jain, N Thakur, BP Gupta, J Banweer, S Jain
    Der Pharmacia Lettre 2 (3), 249-54 , 2010
    2010
    Citations: 23
  • Formulation, Optimization and Evaluation of Matrix type Transdermal system of Lisinopril Dihydrate Using Permeation Enhancers.
    J Banweer, S Pandey, AK Pathak
    Drug Invention Today 2 (2) , 2010
    2010
    Citations: 20
  • A comprehensive review on floating oral drug delivery system.
    N Thakur, BP Gupta, D Patel, SK Chaturvedi, NP Jain, J Banweer
    Drug Invention Today 2 (7) , 2010
    2010
    Citations: 17
  • Nutraceutical: new era's safe pharmaceuticals.
    NT Navneet Thakur, BP Gupta, AK Nagariya, NP Jain, ...
    2010
    Citations: 15
  • Development and Optimization of Transdermal System of Lisinopril dehydrate: Employing Permeation Enhancers
    SP JITENDRA BANWEER, ANUPAM KUMAR PATHAK
    IRANIAN JOURNAL OF PHARMACEUTICAL SCIENCES 2, 245-251 , 2010
    2010
    Citations: 14
  • Development and validation of a rapid RP-HPLC method for the determination of amlodipine besylate and olmesartan medoxomil in their combined tablet formulation
    N Jain, R Jain, J Banweer, DK Jain
    Int J Curr Pharm Res 2 (2), 40-3 , 2010
    2010
    Citations: 11
  • Formulation, optimization and evaluation of matrix type transdermal system of Lisinopril dehydrate using penetration enhancers
    B Jitendra
    Drug Invention Today 2, 134-137 , 2010
    2010
    Citations: 6
  • Rosmarinic Acid-A Potential Therapeutic Agent for Sleep Disorders.
    BJ Morde A, Acharya M, Tahilani P
    International Journal on Pharmacy & Sciences 3 (1), 1-6 , 2023
    2023
    Citations: 4
  • Herbal chewing Gum to Treat Mouth Ulcer using Guava Leaf and Turmeric Rhizomes
    SS Mishra P, Banweer J, Tahilani P, Samundre P
    International Journal of Clinical Studies & Medical Case Reports 5 (1), 1-4 , 2022
    2022
    Citations: 4
  • HYPOLIPIDEAMIC AND HEPATOPROTECTIVE ACTIVITY OF GYNURA NEPALENSISDC FLOWER EXTRACT IN STREPTOZOTOCIN INDUCED DIABETIC MICE
    jitendra banweer
    WORLD JOURNAL OF PHARMACEEUTICAL RESEARCH 2 (1) , 2012
    2012
    Citations: 3
  • Advances in Ocular Drug Delivery System for Glaucoma Management–A Comprehensive Review
    R Maski, J Banweer, M Mishra, P Tahilani, G Goyanar
    Indian Journal of Pharmacy & Drug Studies 1 (2), 38-46 , 2022
    2022
    Citations: 2